kaonavi
4435
D. Western Therapeutics Institute
4576
Itamiarts
168A
Nakayo
6715
Allied Telesis Holdings KK
6835
(FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | (FY)Dec 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 4.03%20.26B | 13.81%19.48B | -11.85%17.11B | 0.02%19.41B | 22.42%19.41B | 43.56%15.86B | -16.08%11.05B | 7.10%13.16B | 5.35%12.29B | 53.45%11.66B |
Net profit before non-cash adjustment | 26.49%22.65B | 17.36%17.91B | -10.09%15.26B | 46.82%16.97B | -18.51%11.56B | -1.13%14.19B | -0.85%14.35B | 0.56%14.47B | 9.50%14.39B | 54.71%13.14B |
Total adjustment of non-cash items | -51.14%3.82B | 13.85%7.82B | 71.61%6.87B | -43.26%4B | 44.56%7.05B | 16.39%4.88B | 57.53%4.19B | -9.15%2.66B | -2.11%2.93B | 356.79%2.99B |
-Depreciation and amortization | -2.28%6.09B | -6.89%6.23B | -3.84%6.69B | 5.60%6.96B | 34.39%6.59B | 34.56%4.9B | 30.85%3.64B | 13.68%2.78B | 3.07%2.45B | 57.04%2.38B |
-Reversal of impairment losses recognized in profit and loss | --0 | --45M | --0 | ---- | ---- | ---- | --86M | ---- | -48.33%31M | --60M |
-Disposal profit | -470.19%-2.6B | --701M | --0 | ---3.47B | ---- | ---- | 86.49%207M | 909.09%111M | 22.22%11M | --9M |
-Other non-cash items | -61.14%328M | 374.16%844M | -65.17%178M | 9.89%511M | 2,121.74%465M | -108.98%-23M | 209.40%256M | -153.42%-234M | -19.93%438M | 163.75%547M |
Changes in working capital | 0.66%-6.21B | -24.67%-6.25B | -221.47%-5.02B | -295.73%-1.56B | 124.84%797M | 57.20%-3.21B | -88.91%-7.5B | 21.18%-3.97B | -12.67%-5.03B | -188.82%-4.47B |
-Change in receivables | -13.76%-3.2B | 17.22%-2.81B | 2.80%-3.4B | -819.34%-3.5B | 196.05%486M | 80.74%-506M | -5.59%-2.63B | -66.87%-2.49B | -5.67%-1.49B | -242.81%-1.41B |
-Change in inventory | 19.65%-4.38B | -87.51%-5.45B | -184.62%-2.91B | -149.85%-1.02B | 134.88%2.05B | -13.73%-5.87B | -85.28%-5.16B | 31.01%-2.79B | -23.98%-4.04B | -124.78%-3.26B |
-Change in payables | -27.32%1.37B | 46.24%1.89B | -56.36%1.29B | 270.06%2.95B | -154.81%-1.74B | 981.57%3.17B | -77.57%293M | 163.84%1.31B | 147.50%495M | 118.43%200M |
-Provision for loans, leases and other losses | -102.40%-3M | --125M | --0 | --3M | --0 | --0 | --0 | --0 | --0 | --0 |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -142.57%-245M | -14.77%-101M | 0.00%-88M | -4.76%-88M | -23.53%-84M | -58.14%-68M | -437.50%-43M | -8M | ||
Interest received (cash flow from operating activities) | 9.46%81M | 27.59%74M | 38.10%58M | 16.67%42M | -2.70%36M | 23.33%37M | 11.11%30M | -15.63%27M | -25.58%32M | 95.45%43M |
Tax refund paid | -53.95%-7.07B | 6.32%-4.6B | -44.60%-4.91B | 21.02%-3.39B | 11.02%-4.3B | -17.62%-4.83B | 3.37%-4.1B | 27.53%-4.25B | -147.15%-5.86B | 45.63%-2.37B |
Other operating cash inflow (outflow) | 98.08%-1M | -52M | 0 | -50M | 0 | 0 | 0 | 0.00%-1M | -1M | 0 |
Operating cash flow | -12.03%13.02B | 21.55%14.8B | -23.53%12.18B | 5.69%15.93B | 37.01%15.07B | 58.75%11B | -22.44%6.93B | 38.29%8.93B | -30.82%6.46B | 186.12%9.34B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -42.21%-15.63B | -187.99%-10.99B | -30.25%-3.82B | 63.62%-2.93B | 47.71%-8.05B | -10.05%-15.4B | -12.53%-13.99B | -89.34%-12.44B | -69.94%-6.57B | -4.83%-3.87B |
Net intangibles purchase and sale | -27.52%-2.48B | -74.51%-1.94B | -54.72%-1.11B | 11.87%-720M | 79.16%-817M | -16.35%-3.92B | -86.81%-3.37B | -66.11%-1.8B | -106.46%-1.09B | -155.34%-526M |
Net business purchase and sale | ---147M | ---- | ---- | ---- | ---- | ---- | 78.05%-486M | -647.97%-2.21B | 62.34%-296M | -51.74%-786M |
Net investment product transactions | --0 | 118.63%49M | 73.67%-263M | ---999M | ---- | ---340M | ---- | -56.50%87M | 100.00%200M | 304.08%100M |
Net changes in other investments | 93.07%-16M | -955.56%-231M | -48.08%27M | -58.73%52M | 373.91%126M | 84.35%-46M | -12.64%-294M | -366.07%-261M | -833.33%-56M | -108.00%-6M |
Investing cash flow | -39.30%-18.27B | -153.88%-13.11B | -12.38%-5.17B | 47.43%-4.6B | 55.64%-8.74B | -8.61%-19.71B | -9.12%-18.14B | -113.02%-16.63B | -53.57%-7.81B | -15.92%-5.08B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 30.00%6.5B | 171.43%5B | ---7B | --0 | -41.18%10B | 13.33%17B | 50.00%15B | --10B | ---- | ---- |
Net common stock issuance | 50.00%-1M | ---2M | --0 | ---1M | ---- | ---- | 50.00%-2M | 0.00%-4M | 55.56%-4M | -125.00%-9M |
Cash dividends paid | -6.40%-3.26B | -45.28%-3.06B | 5.89%-2.11B | 1.49%-2.24B | 6.72%-2.28B | 2.63%-2.44B | 2.57%-2.51B | -13.86%-2.57B | -44.19%-2.26B | 9.53%-1.57B |
Net other fund-raising expenses | 50.00%-1M | -100.00%-2M | 0.00%-1M | 66.67%-1M | 0.00%-3M | -200.00%-3M | 0.00%-1M | ---1M | ---- | ---- |
Financing cash flow | 67.60%3.24B | 121.21%1.93B | -306.15%-9.11B | -129.05%-2.24B | -46.96%7.72B | 16.54%14.56B | 68.27%12.49B | 428.21%7.42B | -43.62%-2.26B | 9.22%-1.58B |
Net cash flow | ||||||||||
Beginning cash position | 9.35%43.09B | -4.94%39.4B | 28.15%41.45B | 76.45%32.34B | 47.25%18.33B | 19.55%12.45B | -2.53%10.41B | -25.28%10.68B | 23.05%14.3B | -19.74%11.62B |
Current changes in cash | -155.45%-2.01B | 272.68%3.62B | -123.08%-2.1B | -35.31%9.09B | 140.16%14.05B | 358.39%5.85B | 569.12%1.28B | 92.46%-272M | -234.76%-3.61B | 193.73%2.68B |
Effect of exchange rate changes | -9.52%57M | 31.25%63M | 166.67%48M | 154.55%18M | -206.45%-33M | 875.00%31M | -500.00%-4M | 125.00%1M | ---4M | ---- |
Cash adjustments other than cash changes | 0.00%1M | --1M | ---- | ---- | ---- | 100.00%2M | 0.00%1M | 200.00%1M | ---1M | ---- |
End cash Position | -4.53%41.14B | 9.35%43.09B | -4.94%39.4B | 28.15%41.45B | 76.45%32.34B | 56.87%18.33B | 12.23%11.69B | -2.53%10.41B | -25.28%10.68B | 23.05%14.3B |
Free cash flow | -618.38%-8.75B | -76.72%1.69B | -1.16%7.25B | 18.26%7.33B | 174.48%6.2B | 20.25%-8.32B | -95.69%-10.44B | -304.32%-5.33B | -127.75%-1.32B | 844.98%4.75B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |